Cardinal Health announced acquisitions of AdaptHealth's Diabetes Health business and Strive Medical for about $360 million in cash. These deals expand Cardinal's at-Home Solutions, enhancing its capabilities in diabetes management and urology supplies. The acquisitions follow Cardinal's recent purchase of Advanced Diabetes Supply and aim to strengthen its leadership in home healthcare. The transactions are expected to be accretive to earnings within 12 months, pending regulatory approval.
Cardinal Health reported a strong Q4 adjusted EPS of $2.91, beating estimates by 20.25%, driven partly by a one-time tariff refund. Despite missing revenue expectations by nearly 3% with $63.7 billion, the company still achieved 6% year-over-year rev...
Cardinal Health reported a 6% increase in Q4 revenue to $63.7 billion and a 70% rise in GAAP diluted EPS to $1.70, driven by strong pharmaceutical sales and tariff refunds. Fiscal year 2026 revenue grew 14% to $254.2 billion, with non-GAAP diluted EP...
Cardinal Health's Board of Directors approved a quarterly dividend of $0.5158 per share, payable on October 15, 2026, to shareholders recorded by October 1, 2026. The dividend will be paid out from the company's capital surplus. Cardinal Health is a ...
